Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RheaVita
Ghent, Flanders, Belgiumrheavita.com ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
RheaVita has not reported proprietary clinical results; rather, it enables pharmaceutical and biotechnology clients to accelerate lyophilized product development and commercialization through its continuous freeze-drying platform for high-value biologics[3][4][5][7].
- Modalities
- mRNA-based drugsViral vectorsMonoclonal antibodyAntibody-drug conjugateVaccine
- Industry
- Contract Manufacturing Organization
02
Partnerships
IMA Life (strategic partnership for technology and global commercialization, includes investment and manufacturing collaboration)
Beyond the preview
Go deeper on RheaVita.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RheaVita.